Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
New Approaches to Psychedelic Clinical Trials Could Overcome Regulatory Hurdles
Via Investor Brand Network
Exposures Product Safety
Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics
Via News Direct
Exposures Product Safety
Tickers MBOT
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Via Benzinga
Exposures Product Safety
Tickers CKPT
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
Via Benzinga
Exposures Product Safety
Tickers CRNX NBIX
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Purfresh Clean launches its new "SPACE" product - An innovative technology restaurants are using to get rid of their rat and mice problems
Via PRLog
Exposures Product Safety
Neurocrine Wins FDA Approval For Genetic Disorder Drug
Via Investor's Business Daily
Exposures Product Safety
Tickers ABBV NBIX
Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
Via Benzinga
Topics Government
Exposures Political Product Safety
Tickers GSK PFE SNY
Why Is Repare Therapeutics Stock Trading Lower On Friday?
Via Benzinga
Exposures Product Safety
Tickers RPTX
Clene Inc. (NASDAQ: CLNN) Receives FDA Guidance on Accelerated Approval Pathway for CNM-Au8(R) for ALS
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Bill Gates Recalls The Time Warren Buffett Slept Over And Ate Oreos For Breakfast – 'Poor Example For Young People' But It Works For Him
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Medico-Legal Expert Questions Sustainability of Low-Cost, Compounded GLP-1 Drugs for Weight Loss
Via Press Advantage
Topics Lawsuit
Exposures Financial Legal Product Safety
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
Via Newsfile
Topics Government Supply Chain
Exposures Political Product Safety Supply Chain
Tickers XXII
DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids
Via Benzinga
Exposures Product Safety
Tickers DBVT
BOQU Instrument – Pioneering Excellence in Water Quality Analysis
Via AB Newswire
Exposures Product Safety
Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options
Via Benzinga
Exposures Product Safety
Tickers CLRB
Water Tower Research Publishes Initiation of Coverage Report on Vivos Therapeutics, Inc., “New Strategic Model &amp; Key Regulatory Milestones Provide Revenue Tailwind”
Via TheNewswire.com
Exposures Product Safety
Tickers ASX:TWR VVOS
Chimerix Stock Draws Heavy Retail Chatter After Landing Price-Target Hike On FDA Submission Plan For Cancer Drug
Via Stocktwits
Exposures Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Advances CNM-Au8 in ALS with FDA Guidance on Accelerated Approval Pathway
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
Via Benzinga
Exposures Product Safety
Tickers CPIX
uniQure Stock Hits 18-Month High After FDA Agreement Clears Pathway For Huntington’s Treatment: Retail Gets More Optimistic
Via Stocktwits
Exposures Product Safety
Cumberland Pharma Stock Hits 16-Month High After FDA Approves Liver Drug Regimen: Retail’s Thrilled
Via Stocktwits
Exposures Product Safety
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers CMRX
UniQure Stock Nearly Doubles After Striking A Deal With The FDA For Huntington's Drug
Via Investor's Business Daily
Exposures Product Safety
Tickers NVS PTCT QURE
Why Is uniQure Stock Skyrocketing On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers BBC QURE
APLT ALERT: Kaplan Fox &amp; Kilsheimer LLP Is Investigating Applied Therapeutics, Inc. (APLT) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awaits FDA Decision on New Fibromyalgia Treatment
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Slate360 Provides Valuable Insights on the Advantages of Working with a Skilled Healthcare Event Marketing Agency
Via Prodigy
Exposures Product Safety
APPLIED THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox &amp; Kilsheimer LLP Regarding Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
APPLIED THERAPEUTICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.